The University of Tennessee Health Science Center and Regional One Health are partnering on a clinical trial program in Memphis to evaluate a drug for COVID-19 treatment. The Memphis medical college and hospital announced Thursday they will provide late-stage trials for Regeneron’s REGN-COV2, an antibody cocktail the company is investigating for possible treatment and prevention… Read More
If a COVID-19 vaccine is widely available in the nation even by next spring, it could be months — even after the start of school next fall — before it’s available for children. The good news is children so far are less affected by the virus. The bad news? If children aren’t vaccinated, they can spread the… Read More
Salvatore Mancarella, PhD, associate professor in the Department of Physiology in the College of Medicine at the University of Tennessee Health Science Center, was recently awarded $1.52 million from the National Institutes of Health (NIH) to support his investigations into the molecular-level causes of cardiac muscle deterioration. Also: BioEngineer
In an opinion article published in Frontiers in Pediatrics, Dr. Arun Saini — an assistant professor in the Division of Critical Care Medicine at the University of Tennessee Health Science Center in Memphis — describes the reasons for physicians seeking a better work-life balance as varied and personal. “Dissatisfaction, depression, and burnout are common in… Read More
Now is the time to prepare for the availability of a safe and effective COVID-19 vaccine, particularly since currently only 65 percent of Americans report they will be willing to get a FDA-approved vaccine provided at no cost. A vaccine will be an essential component to fully reopening schools and businesses and getting back to… Read More
Doctors and researchers say creating a coronavirus vaccine is only half the battle. The other is getting people to actually take it. It’s why companies like Moderna and Pfizer are responding to calls to be more transparent about their processes and protocols. There are several trials happening now to develop a coronavirus vaccine, including a… Read More
COVID-19 vaccine trials are happening all over the country, but they need more participants. According to a 2020 Pew Research study taken in May, 44% of Black people would not get a COVID-19 vaccine if it were available to them at that time. Researchers say getting them to participate in clinical trials is an even… Read More
Ramesh Narayanan, PhD, professor in the Department of Medicine and the Division of Hematology and Oncology at the University of Tennessee Health Science Center, has received a $455,000 grant from the National Cancer Institute for a two-year study of the underlying cause of the development of aggressive prostate cancer in African American men.
